These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36297647)

  • 21. Biomimetic cell membrane-coated DNA nanoparticles for gene delivery to glioblastoma.
    Han S; Lee Y; Lee M
    J Control Release; 2021 Oct; 338():22-32. PubMed ID: 34391836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Co-delivery of TRAIL gene enhances the anti-glioblastoma effect of paclitaxel in vitro and in vivo.
    Zhan C; Wei X; Qian J; Feng L; Zhu J; Lu W
    J Control Release; 2012 Jun; 160(3):630-6. PubMed ID: 22410115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancing Glioblastoma-Specific Penetration by Functionalization of Nanoparticles with an Iron-Mimic Peptide Targeting Transferrin/Transferrin Receptor Complex.
    Kang T; Jiang M; Jiang D; Feng X; Yao J; Song Q; Chen H; Gao X; Chen J
    Mol Pharm; 2015 Aug; 12(8):2947-61. PubMed ID: 26149889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lung cancer gene therapy: Transferrin and hyaluronic acid dual ligand-decorated novel lipid carriers for targeted gene delivery.
    Zhang B; Zhang Y; Yu D
    Oncol Rep; 2017 Feb; 37(2):937-944. PubMed ID: 27959442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted delivery of tumor suppressor microRNA-1 by transferrin-conjugated lipopolyplex nanoparticles to patient-derived glioblastoma stem cells.
    Wang X; Huang X; Yang Z; Gallego-Perez D; Ma J; Zhao X; Xie J; Nakano I; Lee LJ
    Curr Pharm Biotechnol; 2014; 15(9):839-46. PubMed ID: 25374033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual functionalized liposomes for efficient co-delivery of anti-cancer chemotherapeutics for the treatment of glioblastoma.
    Lakkadwala S; Dos Santos Rodrigues B; Sun C; Singh J
    J Control Release; 2019 Aug; 307():247-260. PubMed ID: 31252036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CXCR4-targeted modular peptide carriers for efficient anti-VEGF siRNA delivery.
    Egorova A; Shubina A; Sokolov D; Selkov S; Baranov V; Kiselev A
    Int J Pharm; 2016 Dec; 515(1-2):431-440. PubMed ID: 27789364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intranasal Delivery of Temozolomide-Conjugated Gold Nanoparticles Functionalized with Anti-EphA3 for Glioblastoma Targeting.
    Wang L; Tang S; Yu Y; Lv Y; Wang A; Yan X; Li N; Sha C; Sun K; Li Y
    Mol Pharm; 2021 Mar; 18(3):915-927. PubMed ID: 33417456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physical stability and in-vitro gene expression efficiency of nebulised lipid-peptide-DNA complexes.
    Birchall JC; Kellaway IW; Gumbleton M
    Int J Pharm; 2000 Mar; 197(1-2):221-31. PubMed ID: 10704809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Co-delivery of doxorubicin and erlotinib through liposomal nanoparticles for glioblastoma tumor regression using an in vitro brain tumor model.
    Lakkadwala S; Singh J
    Colloids Surf B Biointerfaces; 2019 Jan; 173():27-35. PubMed ID: 30261346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficient delivery of anti-miR-210 using Tachyplesin, a cell penetrating peptide, for glioblastoma treatment.
    Jana A; Narula P; Chugh A; Kulshreshtha R
    Int J Pharm; 2019 Dec; 572():118789. PubMed ID: 31726199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glutathione-sensitive RGD-poly(ethylene glycol)-SS-polyethylenimine for intracranial glioblastoma targeted gene delivery.
    Lei Y; Wang J; Xie C; Wagner E; Lu W; Li Y; Wei X; Dong J; Liu M
    J Gene Med; 2013; 15(8-9):291-305. PubMed ID: 24038955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. S4(13)-PV cell penetrating peptide and cationic liposomes act synergistically to mediate intracellular delivery of plasmid DNA.
    Trabulo S; Mano M; Faneca H; Cardoso AL; Duarte S; Henriques A; Paiva A; Gomes P; Simões S; de Lima MC
    J Gene Med; 2008 Nov; 10(11):1210-22. PubMed ID: 18729238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A dual-targeting drug co-delivery system for tumor chemo- and gene combined therapy.
    Zhang F; Li M; Su Y; Zhou J; Wang W
    Mater Sci Eng C Mater Biol Appl; 2016 Jul; 64():208-218. PubMed ID: 27127046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retro-inverso CendR peptide-mediated polyethyleneimine for intracranial glioblastoma-targeting gene therapy.
    Wang J; Lei Y; Xie C; Lu W; Wagner E; Xie Z; Gao J; Zhang X; Yan Z; Liu M
    Bioconjug Chem; 2014 Feb; 25(2):414-23. PubMed ID: 24506588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multifunctional peptide-lipid nanocomplexes for efficient targeted delivery of DNA and siRNA into breast cancer cells.
    Wan Y; Dai W; Nevagi RJ; Toth I; Moyle PM
    Acta Biomater; 2017 Sep; 59():257-268. PubMed ID: 28655658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain Targeting by Liposome-Biomolecular Corona Boosts Anticancer Efficacy of Temozolomide in Glioblastoma Cells.
    Arcella A; Palchetti S; Digiacomo L; Pozzi D; Capriotti AL; Frati L; Oliva MA; Tsaouli G; Rota R; Screpanti I; Mahmoudi M; Caracciolo G
    ACS Chem Neurosci; 2018 Dec; 9(12):3166-3174. PubMed ID: 30015470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glutathione-Responsive Multilayer Coated Gold Nanoparticles for Targeted Gene Delivery.
    Yu F; Huang J; Yu Y; Lu Y; Chen Y; Zhang H; Zhou G; Sun Z; Liu J; Sun D; Zhang G; Zou H; Zhong Y
    J Biomed Nanotechnol; 2016 Mar; 12(3):503-15. PubMed ID: 27280248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell-surface glycosaminoglycans inhibit intranuclear uptake but promote post-nuclear processes of polyamidoamine dendrimer-pDNA transfection.
    Ziraksaz Z; Nomani A; Ruponen M; Soleimani M; Tabbakhian M; Haririan I
    Eur J Pharm Sci; 2013 Jan; 48(1-2):55-63. PubMed ID: 23131796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peptide and nucleic acid-directed self-assembly of cationic nanovehicles through giant unilamellar vesicle modification: Targetable nanocomplexes for in vivo nucleic acid delivery.
    Tagalakis AD; Maeshima R; Yu-Wai-Man C; Meng J; Syed F; Wu LP; Aldossary AM; McCarthy D; Moghimi SM; Hart SL
    Acta Biomater; 2017 Mar; 51():351-362. PubMed ID: 28110069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.